Skip to main content
Clinical Trials/NCT05643378
NCT05643378
Not Yet Recruiting
N/A

Role and Outcome of Endovascular Revacularization of Chronic Limb Threatening Ischaemia in Patients With Chronic Kidney Diseases

Mahmoud Abdelmohsen Mostafa Osman0 sites100 target enrollmentDecember 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Limb Ischemia, Critical
Sponsor
Mahmoud Abdelmohsen Mostafa Osman
Enrollment
100
Primary Endpoint
one year evaluation for maintaining vessel patency without restenosis or need for re intervention in 100 participants
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

identify the safety and efficacy of percutaneous transluminal angioplasty in critical limb ischaemia patients with chronic kidney dieases

Detailed Description

patients with chronic kidney diseases are at higher risk of developing peripheral artery diseases needing revascularization of diseased arteries via endovascular transluminal angioplasty

Registry
clinicaltrials.gov
Start Date
December 1, 2022
End Date
October 1, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Mahmoud Abdelmohsen Mostafa Osman
Responsible Party
Sponsor Investigator
Principal Investigator

Mahmoud Abdelmohsen Mostafa Osman

principle investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • all patients with chronic kidney diseases on medical treatment or on dialysis and have critical limb ischaemia

Exclusion Criteria

  • patients with acute renal failure and lower limb ischaemia.
  • chronic kidney diseased patients underwent previous intervention or surgery for lower limb ischaemia.
  • patients presented with acute limb ischaemia

Outcomes

Primary Outcomes

one year evaluation for maintaining vessel patency without restenosis or need for re intervention in 100 participants

Time Frame: baseline

all patients will be scheduled for follow up visits every 3 months for 1 year assessing primary patency and major adverse limb events. duplex scanning will be performed for all patients

Similar Trials